Measuring signal transduction and transcription molecules for clinical use

[1]Marks F, Klingmuller U, Muller-Decker K. Cellular signal processing. 2nd ed. New York: Garland Science; 2017.MarksFKlingmullerUMuller-DeckerKCellular signal processing2nd edNew YorkGarland Science201710.4324/9781315165479Search in Google Scholar

[2]McCubrey JA, Steelman LS, Chappell WH, Sun L, Davis NM, Abrams SL. Advances in targeting signal transduction pathways. Oncotarget. 2012; 3:1505–21.McCubreyJASteelmanLSChappellWHSunLDavisNMAbramsSLAdvances in targeting signal transduction pathwaysOncotarget2012315052110.18632/oncotarget.802Search in Google Scholar

[3]Wilson J, Hunt T. Molecular biology of the cell. 6th ed. New York: Garland Science; 2015.WilsonJHuntTMolecular biology of the cell6th edNew YorkGarland Science2015Search in Google Scholar

[4]Archbold HC, Yang YX, Chen L, Cadigan KM. How do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathway. Acta Physiol (Oxf.). 2012; 204:74–109.ArchboldHCYangYXChenLCadiganKMHow do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathwayActa Physiol (Oxf.)20122047410910.1111/j.1748-1716.2011.02293.xSearch in Google Scholar

[5]Kafri P, Hasenson SE, Kanter I, Sheinberger J, Kinor N, Yunger S, Shav-Tal Y. Quantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cells. Elife. 2016; 5:e16748. doi: 10.7554/eLife.16748KafriPHasensonSEKanterISheinbergerJKinorNYungerSShav-TalYQuantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cellsElife20165e1674810.7554/eLife.16748Open DOISearch in Google Scholar

[6]Jordan JD, Landau EM, Iyengar R. Signaling networks: the origins of cellular multitasking. Cell. 2000; 103:193–200.JordanJDLandauEMIyengarRSignaling networks: the origins of cellular multitaskingCell200010319320010.1016/S0092-8674(00)00112-4Search in Google Scholar

[7]MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17:9–26.MacDonaldBTTamaiKHeXWnt/beta-catenin signaling: components, mechanisms, and diseasesDev Cell20091792610.1016/j.devcel.2009.06.016286148519619488Search in Google Scholar

[8]Donmez HG. β-Catenin in cervicovaginal smears during regular menstrual cycles. Asian Biomed (Res Rev News). 2020; 14:187–94.DonmezHGβ-Catenin in cervicovaginal smears during regular menstrual cyclesAsian Biomed (Res Rev News)2020141879410.1515/abm-2020-0027Search in Google Scholar

[9]Zhang Z, Wang X, Zhang L, Shi Y, Wang J, Yan H. Wnt/β-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsia. Mol Med Rep. 2017; 16:1007–13.ZhangZWangXZhangLShiYWangJYanHWnt/β-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsiaMol Med Rep20171610071310.3892/mmr.2017.671829067442Search in Google Scholar

[10]Nguyen VHL, Hough R, Bernaudo S, Peng C. Wnt/β-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J Ovarian Res. 2019; 12:122. doi: 10.1186/s13048-019-0596-zNguyenVHLHoughRBernaudoSPengCWnt/β-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesisJ Ovarian Res20191212210.1186/s13048-019-0596-z690504231829231Open DOISearch in Google Scholar

[11]Katoh M, Katoh M. Molecular genetics and targeted therapy of WNT-related human diseases. Int J Mol Med. 2017; 40:587–606.KatohMKatohMMolecular genetics and targeted therapy of WNT-related human diseasesInt J Mol Med20174058760610.3892/ijmm.2017.3071554794028731148Search in Google Scholar

[12]Zhou Y, Wang T, Hamilton JL, Chen D. Wnt/β-catenin signaling in osteoarthritis and in other forms of arthritis. Curr Rheumatol Rep. 2017; 19:53. doi: 10.1007/s11926-017-0679-zZhouYWangTHamiltonJLChenDWnt/β-catenin signaling in osteoarthritis and in other forms of arthritisCurr Rheumatol Rep2017195310.1007/s11926-017-0679-z567280128752488Open DOISearch in Google Scholar

[13]Mercer KE, Hennings L, Ronis MJ. Alcohol consumption, Wnt/β-catenin signaling, and hepatocarcinogenesis. In: Vasiliou V, Zakhari S, Seitz H, Hoek J, editors. Biological basis of alcohol-induced cancer. Advances in Experimental Medicine and Biology, vol 815. Cham: Springer; 2015, p. 185–95.MercerKEHenningsLRonisMJAlcohol consumption, Wnt/β-catenin signaling, and hepatocarcinogenesisIn:VasiliouVZakhariSSeitzHHoekJeditors.Biological basis of alcohol-induced cancer. Advances in Experimental Medicine and Biology815ChamSpringer20151859510.1007/978-3-319-09614-8_11560015525427908Search in Google Scholar

[14]Chen N, Wang J. Wnt/β-Catenin signaling and obesity. Front Physiol. 2018; 9:792. doi: 10.3389/fphys.2018.00792ChenNWangJWnt/β-Catenin signaling and obesityFront Physiol2018979210.3389/fphys.2018.00792605673030065654Open DOISearch in Google Scholar

[15]Zhou L, Liu Y. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat Rev Nephrol. 2015; 11:535–45.ZhouLLiuYWnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney diseaseNat Rev Nephrol2015115354510.1038/nrneph.2015.88486970126055352Search in Google Scholar

[16]Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu J, et al. Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer. Int J Oncol. 2016; 48:2236–46.WuCZhuangYJiangSLiuSZhouJWuJInteraction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancerInt J Oncol20164822364610.3892/ijo.2016.348027082441Search in Google Scholar

[17]Ghahhari NM, Babashah S. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer. 2015; 51:1638–49.GhahhariNMBabashahSInterplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancerEur J Cancer20155116384910.1016/j.ejca.2015.04.02126025765Search in Google Scholar

[18]Ashihara E, Takada T, Maekawa T. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies. Cancer Sci. 2015; 106:665–71.AshiharaETakadaTMaekawaTTargeting the canonical Wnt/β-catenin pathway in hematological malignanciesCancer Sci20151066657110.1111/cas.12655447179725788321Search in Google Scholar

[19]Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018; 62:50–60.KrishnamurthyNKurzrockRTargeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitorsCancer Treat Rev201862506010.1016/j.ctrv.2017.11.002574527629169144Search in Google Scholar

[20]Ghosh N, Hossain U, Mandal A, Sil PC. The Wnt signaling pathway: a potential therapeutic target against cancer. Ann N Y Acad Sci. 2019; 1443:54–74.GhoshNHossainUMandalASilPCThe Wnt signaling pathway: a potential therapeutic target against cancerAnn N Y Acad Sci20191443547410.1111/nyas.1402731017675Search in Google Scholar